XML 42 R20.htm IDEA: XBRL DOCUMENT
v3.25.4

Basic and Diluted Net Loss Per Share | 9 Months Ended | 12 Months Ended
--- | --- | ---
Sep. 28, 2025 | Dec. 29, 2024
Basic and Diluted Net Loss Per Share [Abstract] |  |
Basic and Diluted Net Loss Per Share | (14) Basic and Diluted Net Loss Per Share The Company uses the two-class method to calculate net loss per share. No dividends were declared or paid in the thirteen and thirty-nine week periods ended September 28, 2025 and September 29, 2024. The following table sets forth the computation of the Company’s basic and diluted net loss per share attributable to common stockholders for the thirteen and thirty-nine week periods ended September 28, 2025 and September 29, 2024 (in thousands, except share and per share amounts):
|  | Thirteen Weeks Ended |  |  | Thirty-Nine Weeks Ended |
|  | September 28, 2025 |  |  | September 29, 2024 |  |  | September 28, 2025 |  |  | September 29, 2024 |
Numerator: |  |  |  |  |  |  |  |  |  |  |  |
Net loss from continuing operations |  | $ | (15,804 | ) |  | $ | (77,958 | ) |  | $ | (30,099 | ) |  | $ | (101,433 | )
Net loss from discontinued operations |  |  | (1,100 | ) |  |  | — |  |  |  | (1,100 | ) |  |  | (2,007 | )
Net loss |  | $ | (16,904 | ) |  | $ | (77,958 | ) |  | $ | (31,199 | ) |  | $ | (103,440 | )
Denominator: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Weighted average common shares outstanding, basic and diluted |  |  | 84,904,228 |  |  |  | 75,348,627 |  |  |  | 82,036,790 |  |  |  | 61,868,747 |
Net loss per share, basic and diluted: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Continuing operations |  | $ | (0.19 | ) |  | $ | (1.03 | ) |  | $ | (0.37 | ) |  | $ | (1.64 | )
Discontinued operations |  |  | (0.01 | ) |  |  | — |  |  |  | (0.01 | ) |  |  | (0.03 | )
Net loss |  | $ | (0.20 | ) |  | $ | (1.03 | ) |  | $ | (0.38 | ) |  | $ | (1.67 | )
The computation of basic net loss per share attributable to common stockholders is inclusive of warrants with an insignificant exercise price. The Company’s calculation of the weighted average shares outstanding is inclusive of 234,610 warrants with an insignificant exercise price (which assumes that the warrants were outstanding as of the beginning of the period or the date of the grant, whichever is earlier) for each of the thirteen and thirty-nine week periods ended September 28, 2025, respectively. The computation of diluted net loss per share attributable to common stockholders is the same for the thirteen and thirty-nine week periods ended September 28, 2025 and September 29, 2024 because the inclusion of potential shares of common stock would have been anti-dilutive for the periods presented. The following table presents the potential common shares outstanding that were excluded from the computation of diluted net loss per share of common stock as of the periods presented because including them would have been anti-dilutive:
|  | Thirteen Weeks Ended |  |  | Thirty-Nine Weeks Ended |
|  | September 28, 2025 |  |  | September 29, 2024 |  |  | September 28, 2025 |  |  | September 29, 2024 |
Common stock warrants |  |  | 25,670,265 |  |  |  | 31,670,265 |  |  |  | 25,670,265 |  |  |  | 31,670,265 |
Stock options and RSUs issued and outstanding |  |  | 34,256,501 |  |  |  | 14,170,385 |  |  |  | 34,256,501 |  |  |  | 14,170,385 |
Convertible notes |  |  | 77,821,528 |  |  |  | 58,579,636 |  |  |  | 77,821,528 |  |  |  | 58,579,636 |
Third SAFE Agreement |  |  | 2,750,000 |  |  |  | — |  |  |  | 2,750,000 |  |  |  | — |
Forward Purchase Agreements |  |  | 6,720,000 |  |  |  | — |  |  |  | 6,720,000 |  |  |  | — |
Deferred consideration shares |  |  | 6,666,666 |  |  |  | — |  |  |  | 6,666,666 |  |  |  | — |
Total potential common shares excluded from diluted net loss per share |  |  | 153,884,960 |  |  |  | 104,420,286 |  |  |  | 153,884,960 |  |  |  | 104,420,286 |
| (21) Basic and Diluted Net Loss Per Share The Company uses the two-class method to calculate net loss per share. No dividends were declared or paid for the fiscal years ended December 29, 2024 and December 31, 2023. The following table sets forth the computation of the Company’s basic and diluted net loss per share attributable to common stockholders for the fiscal years ended December 29, 2024 and December 31, 2023 (in thousands, except share and per share amounts):
|  | Fiscal Year Ended |
|  | December 29, |  |  | December 31, |
|  | 2024 |  |  | 2023 |
Numerator for basic loss per share: |  |  |  |  |  |
Net loss from continuing operations |  | $ | (54,444 | ) |  | $ | (96,197 | )
Net loss from discontinued operations |  |  | (2,007 | ) |  |  | (25,853 | )
Impairment loss from discontinued operations |  |  | - |  |  |  | (147,505 | )
Net loss |  |  | (56,451 | ) |  |  | (269,555 | )
Numerator for diluted loss per share |  |  |  |  |  |  |  |
Impact of 7% Notes derivative liability and interest expense, net of tax |  |  | (35,886 | ) |  |  | - |
Net loss |  | $ | (92,337 | ) |  | $ | (269,555 | )
Denominator: |  |  |  |  |  |  |  |
Weighted average shares: |  |  |  |  |  |  |  |
Denominator for basic loss per share |  |  | 66,655,837 |  |  |  | 24,723,370 |
Effect of dilutive securities: |  |  |  |  |  |  |  |
7% Notes derivative liability |  |  | 9,137,711 |  |  |  | - |
Denominator for diluted loss per share |  |  | 75,793,548 |  |  |  | 24,723,370 |
Net loss per share: |  |  |  |  |  |  |  |
Continuing operations - basic |  | $ | (0.82 | ) |  | $ | (3.89 | )
Discontinued operations - basic |  |  | (0.03 | ) |  |  | (1.05 | )
Net loss - basic |  | $ | (0.85 | ) |  | $ | (4.94 | )
Continuing operations - diluted |  | $ | (1.19 | ) |  | $ | (3.89 | )
Discontinued operations - diluted |  |  | (0.03 | ) |  |  | (1.05 | )
Net loss - diluted |  | $ | (1.22 | ) |  | $ | (4.94 | )
The computation of basic net loss per share attributable to common stockholders is inclusive of warrants with an insignificant exercise price. The Company’s calculation of the weighted average shares outstanding is inclusive of 3,427,324 warrants with an insignificant exercise price (which assumes that the warrants were outstanding as of the beginning of the period or the date of the grant, whichever is earlier) for the fiscal year ended December 29, 2024. The computation of diluted net loss per share attributable to common stockholders is inclusive of the impact of the Company’s 7% Notes (which were dilutive) using the if-converted method for the year ended December 29, 2024. The computation of basic and diluted net loss per share attributable to common stockholders is the same for the fiscal year ended December 31, 2023 because the inclusion of potential shares of common stock would have been anti-dilutive. The following table presents the potential common shares outstanding that were excluded from the computation of diluted net loss per share of common stock as of the periods presented because including them would have been anti-dilutive:
|  | Fiscal Year Ended |
|  | December 29, |  |  | December 31, |
|  | 2024 |  |  | 2023 |
Common stock warrants |  |  | 25,434,069 |  |  |  | 23,024,556 |
Convertible notes |  |  | 27,364,717 |  |  |  | - |
Stock options and RSUs issued and outstanding |  |  | 11,979,368 |  |  |  | 11,774,743 |
Potential common shares excluded from diluted net loss per share |  |  | 64,778,154 |  |  |  | 34,799,299 |

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration